Literature DB >> 29479068

Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations.

Christophe Willekens1,2, Aline Renneville3, Sophie Broutin4, Véronique Saada4, Jean-Baptiste Micol1, Julia Delahousse4, Vianney Poinsignon4, Claire Bories5, Céline Berthon5, Raphael Itzykson6, Nicolas Boissel6, Cyril Quivoron2, Marie Terroir-Cassou-Mounat7, Jacques Bosq4, Claude Preudhomme3, Angelo Paci4, Virginie Penard-Lacronique2, Stéphane De Botton8,9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29479068     DOI： 10.1038/s41375-018-0056-6

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   12.883


× No keyword cloud information.
  4 in total

Review 1.  Target Therapy for Extramedullary Relapse of FLT3-ITD Acute Myeloid Leukemia: Emerging Data from the Field.

Authors:  Andrea Duminuco; Cinzia Maugeri; Marina Parisi; Elisa Mauro; Paolo Fabio Fiumara; Valentina Randazzo; Domenico Salemi; Cecilia Agueli; Giuseppe Alberto Palumbo; Alessandra Santoro; Francesco Di Raimondo; Calogero Vetro
Journal:  Cancers (Basel)       Date:  2022-04-27       Impact factor: 6.575

2.  Progression, transformation, and unusual manifestations of myelodysplastic syndromes and myelodysplastic-myeloproliferative neoplasms: lessons learned from the XIV European Bone Marrow Working Group Course 2019.

Authors:  Konnie Hebeda; Ludmila Boudova; Christine Beham-Schmid; Attilio Orazi; Hans-Michael Kvasnicka; Umberto Gianelli; Alexandar Tzankov
Journal:  Ann Hematol       Date:  2020-10-31       Impact factor: 3.673

3.  Extramedullary acute myeloid leukemia (eAML): Retrospective single center cohort study on clinico-pathological, molecular analysis and survival outcomes.

Authors:  Khalid Halahleh; Yazan Alhalaseh; Dalia Al-Rimawi; Waleed Da'na; Kamal Alrabi; Nazmi Kamal; Isra Muradi; Hikmat Abdel-Razeq
Journal:  Ann Med Surg (Lond)       Date:  2021-10-22

4.  Incidence, clinical characteristics, and prognostic nomograms for patients with myeloid sarcoma: A SEER-based study.

Authors:  Ziping Xing; Xiaohua Zhu; Zifeng Li; Hongsheng Wang; Maoxiang Qian; Xiaowen Zhai
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.